Oncosec Medical intends to sell equity units through public offering

Funds slated for clinical trials, working capital, corporate purposes

By Devika Patel

Knoxville, Tenn., Jan. 24 - Oncosec Medical Inc. plans to sell units of common shares and warrants in a public offering, according to a Form S-1 filed Tuesday with the Securities and Exchange Commission.

Rodman & Renshaw, LLC is the agent.

Proceeds will be used for clinical trials, working capital and general corporate purposes.

The Rolling Meadows, Ill., company provides information technology services.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.